Geula Hanin

Title: Geula Hanin: Innovator in Lipid-Related Disorder Treatments

Introduction

Geula Hanin is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of medical research, particularly in the treatment of lipid-related disorders. Her innovative approach has led to the development of a unique method that addresses these health issues effectively.

Latest Patents

Geula Hanin holds 1 patent for her groundbreaking work titled "Downregulating miR-132 for the treatment of lipid related disorders." This patent discloses a method of treating lipid-related disorders in subjects in need. The method involves administering a therapeutically effective amount of a polynucleotide agent that is substantially complementary to a nucleotide sequence of human miR-132, thereby providing a novel treatment option for patients.

Career Highlights

Throughout her career, Geula has been associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. This affiliation has allowed her to collaborate with leading researchers and contribute to significant advancements in her field. Her work has garnered attention for its potential impact on health and medicine.

Collaborations

Geula has worked alongside esteemed colleagues such as Hermona Soreq and David Greenberg. Their collaborative efforts have further enhanced the research and development of innovative treatments in the medical field.

Conclusion

Geula Hanin's contributions to the treatment of lipid-related disorders exemplify the importance of innovation in medicine. Her patent and collaborative work highlight her commitment to advancing healthcare solutions.